OAV101

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OAV101, covering 2025-06-03 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials [Phase 3]